Category list : Bacterial infections
Sort by: Newest first Oldest first A-Z Z-A
-
Principles of initiating antimicrobial therapy and empiric prescribing Subscription
Healthcare professionals should be aware of the principles of antimicrobial treatment and the need to reduce inappropriate prescribing to retain the effectiveness of drugs currently available.
-
Cut off age for meningitis B vaccine will not change, committee says
The Joint Committee on Vaccination and Immunisation (JCVI), which advises UK health departments on immunisation, has recommended that the meningitis B vaccine should not be extended to all UK children under the age of two.
-
Antibiotics should be prescribed during idelalisib treatment, concludes review
All patients given the cancer drug idelalisib (marketed as Zydelig) should be prescribed antibiotics during treatment and for two to six months after treatment has ended to prevent pneumonia, according to a new Europe-wide proposal.
-
Data back up drive to cut antibiotic prescribing for respiratory infections
A large reduction in antibiotic prescribing for respiratory tract infections only results in a small number of complications, such as pneumonia, new research suggests, a finding that the authors say is “reassuring”.
-
Enhance your knowledge of infectious disease management Subscription
‘The pharmacist’s guide to antimicrobial therapy and stewardship’, by Sarah M Wieczorkiewicz and Carrie A Sincak.
-
EMA recommends approval of antibiotic combination to treat multi-drug resistant bacteria Subscription
A new combination antibacterial drug is being recommended for approval across the European Union (EU).
-
We need to reduce dental consultations in GP surgeries and pharmacies Subscription
The paper by Cope et al. (Dental consultations in UK general practice and antibiotic prescribing rates: a retrospective cohort study, Br J Gen Pract 2016) is a timely update on
-
EMA review confirms pneumonia risk linked to inhaled corticosteroids Subscription
A medicines safety review has confirmed a risk of pneumonia triggered by inhaled corticosteroids in patients with chronic obstructive pulmonary disease but was unable to specify whether there are any differences in risk for different products.
-
Drugs for multidrug-resistant TB are ‘prohibitively expensive’, says MSF Subscription
Just 2% of people with multidrug-resistant tuberculosis have access to drugs that have been on the market for the past two years and which have the potential to save their lives, according to a report by charity Médecins Sans Frontières.
-
FDA approves anthrax treatment Subscription
The US medicines safety watchdog has approved obiltoxaximab (Anthim) for the treatment of inhalational anthrax in combination with other therapies and when other treatments are either unavailable or inappropriate.
Show 10 per page20 per page50 per page
